BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14609767)

  • 1. [Extracorporeal photochemotherapy for treatment of clonal T cell proliferations].
    Plumas J; Drillat P; Jacob MC; Richard MJ; Favrot MC
    Bull Cancer; 2003; 90(8-9):763-70. PubMed ID: 14609767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis: past, present, and future.
    Knobler R; Barr ML; Couriel DR; Ferrara JL; French LE; Jaksch P; Reinisch W; Rook AH; Schwarz T; Greinix H
    J Am Acad Dermatol; 2009 Oct; 61(4):652-65. PubMed ID: 19665258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Photopheresis: new immunomodulatory therapy for T-lymphocite mediated diseases].
    Vagace Valero JM; Alonso Escobar N; De Argila Fernández-Durán D; Vargas Pérez L; Melero Ruiz J; Morán Penco JM; Bajo Gómez R; Pérez Miranda M
    An Med Interna; 2003 Aug; 20(8):421-6. PubMed ID: 14516265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photopheresis: a review.
    Oliven A; Shechter Y
    Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracorporeal photochemotherapy].
    Viguier M; Pouthier F; Tiberghien P; Aubin F
    Transfus Clin Biol; 2010 Feb; 17(1):28-33. PubMed ID: 20042357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photochemotherapy--present and future.
    Knobler R
    Vox Sang; 2000; 78 Suppl 2():197-201. PubMed ID: 10938952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
    Atta M; Papanicolaou N; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis and adjuvant aerosolized granulocyte-macrophage colony-stimulating factor for Sézary syndrome.
    Bouwhuis SA; Markovic SN; McEvoy MT; Pittelkow MR
    Mayo Clin Proc; 2002 Feb; 77(2):197-200. PubMed ID: 11838656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
    Marshall SR
    Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal toxic reactions following photopheresis.
    Vagace JM; Gervasini G; Morais F; Benitez J; Alonso N; de Argila D; Arranz I; Bajo R
    Arch Dermatol; 2007 May; 143(5):622-5. PubMed ID: 17515512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique.
    Ingen-Housz-Oro S; Bussel A; Flageul B; Dubertret L; Michel L; Gachelin G; Kourilsky P; Bachelez H; Musette P
    Transfus Apher Sci; 2003 Feb; 28(1):35-42. PubMed ID: 12620267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Fimiani M; Di Renzo M; Rubegni P
    Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures.
    Perotti C; Torretta L; Viarengo G; Roveda L; Bernuzzi S; Carbone S; Del Fante C; La Torre R; Locatelli F; Bonetti F; Gabba P; Bellosta M; Salvaneschi L
    Haematologica; 1999 Mar; 84(3):237-41. PubMed ID: 10189389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.